Search for Clinical Trials
Combination of Induction Durvalumab and Tremelimumab alone versus Durvalumab and Tremelimumab with chemotherapy for Potentially Resectable Pleural…
Objective:
Study ML41591 is an umbrella trial that will evaluate the efficacy and safety of various therapies in patients with Stage IB, IIA,…
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic…
Background: Studies have reported differences in the care provided according to the sex and race of the patient. A PE in the lungs can lead to…
Objective: To determine the effects of combined therapeutic plasma exchange (TPE), rituximab, and intravenous immunoglobulin (IVIG) in comparison to…
Study Product: CSL312 (Garadacimab, factor XIIa antagonist monoclonal antibody) for treatment of idiopathic pulmonary fibrosis (IPF).
Inclusion…
Study To Evaluate Perioperative Circulating Tumor DNA As A Prognostic Biomarker In Patients Undergoing Neoadjuvant Therapy For Resectable Non-Small…
Objective:
The primary objective is to determine lung cancer–specific survival at 5 years among patients undergoing active surveillance for GGOs.…
A phase 3, prospective, multicenter, double-blind, double-dummy, randomized, active controlled, parallel-group, group-sequential, adaptive, event-…
A study to evaluate regional differences in biomarker values and in clinical outcomes in dyspneic patients
